SynBiotic SE(DE:SBX)
€0.13+0.01 (+12.07%)
DE:SBX
SynBiotic SE financials statements
€0.13
At close:+0.01 (+12.07%)
SynBiotic SE (SBX) Ratios
37 Followers
SynBiotic SE Ratios
DE:SBX's free cash flow for Q2 2024 was €0.00. For the 2024 fiscal year, DE:SBX's free cash flow was increased by €0.00 and operating cash flow was €0.00. See a summary of the company’s cash flow.
| Ratios | Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | ― | 0.81 | 1.40 | 1.46 | 0.84 |
| Quick Ratio | ― | 0.46 | 0.81 | 0.98 | 0.78 |
| Cash Ratio | ― | 0.01 | 0.17 | 0.44 | 0.65 |
| Solvency Ratio | ― | -0.49 | -1.28 | -0.50 | -0.08 |
| Operating Cash Flow Ratio | ― | -0.36 | -1.22 | -0.71 | -0.14 |
| Short-Term Operating Cash Flow Coverage | ― | -4.88 | -10.59 | -687.26 | -11.00 |
| Net Current Asset Value | ― | € -13.06M | € -9.79M | € -13.34M | € -1.84M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | ― | 0.11 | 0.11 | 0.06 | 0.01 |
| Debt-to-Equity Ratio | ― | 0.23 | 0.20 | 0.10 | 0.01 |
| Debt-to-Capital Ratio | ― | 0.19 | 0.16 | 0.09 | 0.01 |
| Long-Term Debt-to-Capital Ratio | ― | 0.14 | 0.12 | 0.07 | 0.01 |
| Financial Leverage Ratio | ― | 2.21 | 1.80 | 1.73 | 1.37 |
| Debt Service Coverage Ratio | ― | -13.13 | -28.23 | -190.79 | -5.36 |
| Interest Coverage Ratio | ― | -57.43 | -47.70 | -119.60 | 126.67 |
| Debt to Market Cap | ― | 0.23 | 0.09 | 0.03 | 0.01 |
| Interest Debt Per Share | ― | 0.82 | 1.12 | 1.12 | 0.25 |
| Net Debt to EBITDA | ― | -0.34 | -0.14 | -0.02 | 7.85 |
| Profitability Margins | |||||
| Gross Profit Margin | ― | 39.01% | 43.75% | 57.38% | 68.33% |
| EBIT Margin | ― | -302.38% | -315.61% | -125.35% | -15.28% |
| EBITDA Margin | ― | -273.68% | -296.03% | -117.13% | -13.09% |
| Operating Profit Margin | ― | -290.35% | -110.34% | -61.55% | 52.95% |
| Pretax Profit Margin | ― | -307.44% | -320.69% | -147.39% | -15.69% |
| Net Profit Margin | ― | -275.31% | -298.35% | -140.39% | -16.09% |
| Continuous Operations Profit Margin | ― | -303.94% | -318.38% | -144.20% | -16.09% |
| Net Income Per EBT | ― | 89.55% | 93.03% | 95.25% | 102.51% |
| EBT Per EBIT | ― | 105.88% | 290.64% | 239.47% | -29.64% |
| Return on Assets (ROA) | ― | -30.44% | -59.97% | -20.98% | -2.51% |
| Return on Equity (ROE) | ― | -67.33% | -107.83% | -36.36% | -3.45% |
| Return on Capital Employed (ROCE) | ― | -41.68% | -25.83% | -10.44% | 11.22% |
| Return on Invested Capital (ROIC) | ― | -40.03% | -25.00% | -10.17% | 11.17% |
| Return on Tangible Assets | ― | -88.95% | -178.56% | -71.36% | -10.49% |
| Earnings Yield | ― | -75.93% | -56.37% | -14.04% | -2.59% |
| Efficiency Ratios | |||||
| Receivables Turnover | ― | 6.83 | 26.69 | 12.46 | 5.94 |
| Payables Turnover | ― | 1.00 | 2.33 | 1.75 | 2.59 |
| Inventory Turnover | ― | 0.83 | 1.35 | 1.11 | 3.30 |
| Fixed Asset Turnover | ― | 0.79 | 1.51 | 1.55 | 236.28 |
| Asset Turnover | ― | 0.11 | 0.20 | 0.15 | 0.16 |
| Working Capital Turnover Ratio | ― | 9.43 | 2.88 | 9.86 | -8.54 |
| Cash Conversion Cycle | ― | 126.06 | 126.91 | 148.07 | 31.01 |
| Days of Sales Outstanding | ― | 53.41 | 13.67 | 29.29 | 61.50 |
| Days of Inventory Outstanding | ― | 438.60 | 270.07 | 327.89 | 110.51 |
| Days of Payables Outstanding | ― | 365.96 | 156.84 | 209.11 | 141.00 |
| Operating Cycle | ― | 492.01 | 283.74 | 357.18 | 172.01 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | ― | -0.62 | -1.69 | -1.66 | -0.79 |
| Free Cash Flow Per Share | ― | -0.62 | -1.81 | -1.77 | -2.14 |
| Dividend Paid and CapEx Coverage Ratio | ― | -152.46 | -14.63 | -14.07 | -0.59 |
| Capital Expenditure Coverage Ratio | ― | -152.46 | -14.63 | -14.07 | -0.59 |
| Operating Cash Flow Coverage Ratio | ― | -0.79 | -1.57 | -1.50 | -3.44 |
| Operating Cash Flow to Sales Ratio | ― | -0.76 | -0.86 | -0.57 | -0.23 |
| Free Cash Flow Yield | ― | -21.02% | -17.29% | -6.08% | -9.99% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | ― | -1.32 | -1.77 | -7.12 | -38.67 |
| Price-to-Sales (P/S) Ratio | ― | 3.63 | 5.29 | 10.00 | 6.22 |
| Price-to-Book (P/B) Ratio | ― | 0.89 | 1.91 | 2.59 | 1.34 |
| Price-to-Free Cash Flow (P/FCF) Ratio | ― | -4.76 | -5.78 | -16.45 | -10.01 |
| Price-to-Operating Cash Flow Ratio | ― | -4.79 | -6.18 | -17.62 | -26.95 |
| Price-to-Earnings Growth (PEG) Ratio | ― | 0.02 | -0.04 | -0.01 | -0.04 |
| Enterprise Value Multiple | ― | -1.66 | -1.93 | -8.56 | -39.68 |
| Enterprise Value | ― | 17.59M | 46.70M | 90.88M | 28.42M |
| EV to EBITDA | ― | -1.66 | -1.93 | -8.56 | -39.68 |
| EV to Sales | ― | 4.56 | 5.72 | 10.03 | 5.19 |
| EV to Free Cash Flow | ― | -5.98 | -6.25 | -16.50 | -8.36 |
| EV to Operating Cash Flow | ― | -6.02 | -6.68 | -17.67 | -22.49 |
| Tangible Book Value Per Share | ― | -1.61 | -1.01 | -1.96 | -0.71 |
| Shareholders’ Equity Per Share | ― | 3.33 | 5.47 | 11.27 | 16.02 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | ― | 0.01 | 0.01 | 0.02 | -0.03 |
| Revenue Per Share | ― | 0.81 | 1.98 | 2.92 | 3.44 |
| Net Income Per Share | ― | -2.24 | -5.90 | -4.10 | -0.55 |
| Tax Burden | ― | 0.90 | 0.93 | 0.95 | 1.03 |
| Interest Burden | ― | 1.02 | 1.02 | 1.18 | 1.03 |
| Research & Development to Revenue | ― | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | ― | 0.23 | 0.13 | 0.16 | 0.13 |
| Stock-Based Compensation to Revenue | ― | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | ― | 0.28 | 0.29 | 0.40 | 1.44 |
Currency in EUR
